120 related articles for article (PubMed ID: 26717601)
1. PLASMINOGEN AND ANGIOSTATIN LEVELS IN FEMALE BENIGN BREAST LESIONS.
Tykhomyrov AA; Vovchuk IL; Grinenko TV
Ukr Biochem J; 2015; 87(5):103-12. PubMed ID: 26717601
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids.
van Tilborg AA; Sweep FC; Geurts-Moespot AJ; Wetzels AM; de Waal RM; Westphal JR; Massuger LF
Int J Oncol; 2014 Apr; 44(4):1394-400. PubMed ID: 24535412
[TBL] [Abstract][Full Text] [Related]
4. [P21 expression of ras oncogene product in benign and malignant female mammary lesions].
Zhang JZ; Fan SC; Liu HF
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):302-3. PubMed ID: 7874767
[TBL] [Abstract][Full Text] [Related]
5. Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells.
Binda MM; Matar P; González AD; Rozados VR; Gervasoni SI; Scharovsky OG; Bonfil RD
Int J Cancer; 2002 Jul; 100(1):14-21. PubMed ID: 12115581
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the microvasculature and tissue type ratios in normal vs. benign and malignant breast tissue.
Wells WA; Daghlian CP; Tosteson TD; Grove MR; Poplack SP; Knowlton-Soho S; Paulsen KD
Anal Quant Cytol Histol; 2004 Jun; 26(3):166-74. PubMed ID: 15218693
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
8. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 in fine-needle aspirates from breast carcinoma and benign breast diseases.
Sucić M; Boban D; Marković-Glamocak M; Jakić-Razumović J; Vrbanec D; Ries S; Gjadrov-Kuvezdić K; Cobanov AM; Podolski P; Martinović I; Erak V; Budisić Z; Ivrlac R; Unusić J
Breast; 2003 Feb; 12(1):51-7. PubMed ID: 14659355
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum proteases hydrolyze plasminogen, generating angiostatin-like fragments.
Melo PM; Bagnaresi P; Paschoalin T; Hirata IY; Gazarini ML; Carmona AK
Mol Biochem Parasitol; 2014 Jan; 193(1):45-54. PubMed ID: 24503144
[TBL] [Abstract][Full Text] [Related]
11. Angiostatins decrease in the kidney of newborn piglets after hypoxia-reoxygenation.
Emara M; Obaid L; Johnson S; Bigam DL; Cheung PY
Eur J Pharmacol; 2010 Oct; 644(1-3):203-8. PubMed ID: 20621087
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical studies on expression of human vascular smooth muscle myosin heavy chain isoforms in normal mammary glands, benign mammary disorders and mammary carcinomas.
Ohyabu I; Takasaki T; Akiba S; Nomura S; Enokizono N; Sagara Y; Hiroi J; Nagai R; Yoshida H
Pathol Int; 1998 Jun; 48(6):433-9. PubMed ID: 9702855
[TBL] [Abstract][Full Text] [Related]
13. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
[TBL] [Abstract][Full Text] [Related]
14. Angiostatin and plasminogen share binding to endothelial cell surface actin.
Dudani AK; Ben-Tchavtchavadze M; Porter S; Tackaberry E
Biochem Cell Biol; 2005 Feb; 83(1):28-35. PubMed ID: 15746964
[TBL] [Abstract][Full Text] [Related]
15. Trace element content in breasts with fibrocystic disease.
Kanias GD; Kouri E; Arvaniti H; Karaiosifidi H; Kouneli S
Biol Trace Elem Res; 1994; 43-45():363-70. PubMed ID: 7710850
[TBL] [Abstract][Full Text] [Related]
16. [Methodological approaches to quantitative immunohistochemical evaluation of expression of breast apoptosis and proliferation markers].
Kostiuchek IN; Kogan IIu; Kvetnoĭ IM
Arkh Patol; 2006; 68(1):47-8. PubMed ID: 16544540
[TBL] [Abstract][Full Text] [Related]
17. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions.
Ntziachristos V; Yodh AG; Schnall MD; Chance B
Neoplasia; 2002; 4(4):347-54. PubMed ID: 12082551
[TBL] [Abstract][Full Text] [Related]
18. Lectin binding patterns in benign and malignant lesions of the breast.
Karuna V; Shanthi P; Madhavan M
Indian J Pathol Microbiol; 1992 Oct; 35(4):289-97. PubMed ID: 1344218
[TBL] [Abstract][Full Text] [Related]
19. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
[TBL] [Abstract][Full Text] [Related]
20. Mouse macrophage metalloelastase generates angiostatin from plasminogen and suppresses tumor angiogenesis in murine colon cancer.
Xu Z; Shi H; Li Q; Mei Q; Bao J; Shen Y; Xu J
Oncol Rep; 2008 Jul; 20(1):81-8. PubMed ID: 18575722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
